Rat paw volume in ml ± S.E.M (% inhibition) | |||||
---|---|---|---|---|---|
Groups | Day 0 | Day 7 | Day 14 | Day 21 | Day 28 |
Group I | 0.22 ± 0.05 | 0.25 ± 0.09 | 0.21 ± 0.05 | 0.22 ± 0.09 | 0.21 ± 0.08 |
Group II | 0.27 ± 0.03 | 0.82 ± 0.05 a* | 0.80 ± 0.09 a* | 0.71 ± 0.12 a* | 0.77 ± 0.09 a* |
Group III |
0.26 ± 0.01 (0.037%) |
0.53 ± 0.03 a*b* (35.36%) |
0.40 ± 0.05a* b* (50%) |
0.42 ± 0.05 a*b* (40.84%) |
0.38 ± 0.07 a#b* (50.64%) |
Group IV | 0.20 ± 0.07 | 0.23 ± 0.05 b* | 0.25 ± 0.01 b* | 0.26 ± 0.11 b* | 0.22 ± 0.03b* |
Group V |
0.26 ± 0.06 (0.037%) |
0.58 ± 0.04 a*b* (29.26%) |
0.48 ± 0.08 a*b* (40%) |
0.46 ± 0.09 a*b* (35.21%) |
0.42 ± 0.02 a*b* (45.45%) |
Group VI |
0.24 ± 0.08 (11.11%) |
0.62 ± 0.09 a*b* (24.39%) |
0.52 ± 0.09 a*b* (35%) |
0.52 ± 0.07 a*b* (26.76%) |
0.50 ± 0.04 a*b* (35.06%) |
Group VII | 0.25 ± 0.04 | 0.25 ± 0.08 b* | 0.26 ± 0.07 b* | 0.26 ± 0.05 b* | 0.21 ± 0.01b* |
Group VIII |
0.28 ± 0.09 (0.037%) |
0.54 ± 0.05 a*b# c@
(34.14%) |
0.50 ± 0.09 a*b* c#
(37.5%) |
0.49 ± 0.04 a*b*c@
(30.98%) |
0.45 ± 0.11 a*b* (41.56%) |
Group IX |
0.24 ± 0.05 (11.11%) |
0.67 ± 0.11 a*b* (18.29%) |
0.54 ± 0.08 a* b* c@
(32.5%) |
0.52 ± 0.08 a*b* (26.76%) |
0.52 ± 0.10 a*b* (32.46%) |